<DOC>
	<DOCNO>NCT01294215</DOCNO>
	<brief_summary>This clinical study evaluate safety efficacy long term administration oral BAYA1040_Nifedipine 80 mg/day ( 40 mg twice daily ) antihypertensives patient essential hypertension target blood pressure combination BAYA1040_Nifedipine 40 mg daily antihypertensive .</brief_summary>
	<brief_title>High Dose BAYA1040_Nifedipine : Long Term Combination Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>20 year old Japanese male female Outpatient essential hypertension Patients treat Adalat CR 40 mg od least one antihypertensive drug ( Ca antagonists ) 4 week entry study Patients whose sit diastolic blood pressure ( DBP ) 110 mm Hg Patients secondary hypertension hypertensive emergency</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>BAYA1040</keyword>
	<keyword>Nifedipine</keyword>
	<keyword>Essential hypertension</keyword>
	<keyword>Japanese Patients</keyword>
	<keyword>Phase III</keyword>
	<keyword>combination study</keyword>
	<keyword>14024</keyword>
</DOC>